← Eichor
Study identifier: NCT07400926 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg

Condition: Open Angle Glaucoma (OAG) · Ocular Hypertension (OH)  ·  Sponsor: Glaukos Corporation

PhaseN/A
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)

This description comes directly from the study's public registry record.

Talk to the study team

Study Director  ·  949-739-8749  ·  ClinicalResearch@glaukos.com

Always discuss trial participation with your own doctor first.

Locations (1)

Glaukos Investigative SiteKenosha, Wisconsin, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07400926